The Partnering Yearbook 2012 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2011. http://www.bharatbook.com/
* Bigpharma partnering activity during 2011
* Top partnering deals by value in 2011
* Most active dealmakers 2011
* Comprehensive coverage of every deal announced in 2011
The Partnering Yearbook 2012 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2011.
Using this report, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report allows you to view all the partnering, alliances deals announced worldwide.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of partnering trends, respectively, in 2011. The key partnering deals of 2011 are reviewed, as well as forecasts for dealmaking in 2012.
Chapter 3 analyzes the most active dealmakers in partnering during 2011.
Chapter 4 provides an overview of the leading deals for 2011 by headline value.
The main body of the report is provided in chapters 5 and 6.
Chapter 5 provides an in-depth review of every bigpharma company provides the reader with a breakdown of that company’s dealmaking during 2011 by deal type, stage of development and therapy focus. Each company entry is supplemented with a comprehensive listing of deals entered into during 2011, complete with a hyperlink to the deal record online. Where a contract document is available, this may also be found in the deal record online as filed with the SEC.
Chapter 6 provides a comprehensive directory of partnering activity during 2011. The deals are listed by company A-Z, industry sector, deal type, stage of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the deal record at the Current Agreements deals and alliances database. Where available, deal records also include the contract document as disclosed at the SEC.
One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.
Understanding the flexibility of prospective partners’ negiotated deals terms provides critical insight into the negotiation process in termsof what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each parties ability to derive value from the deal.
In summary, the report provides the reader with the resources necessary to make research and understand the partnerships and alliances deals of 2011
Partnering Yearbook 2012 provides the reader with the following key benefits:
* In-depth understanding of dealmaking trends in 2011
* Comprehensive access to over 3,500 partnering deals entered into by the world’s biopharma companies during 2011
* Detailed access to actual partnership deals and contracts entered into by the leading fifty bigpharma companies
* Understand the key deal terms companies have agreed in previous deals
* Undertake due diligence to assess suitability of your proposed deal terms for partner companies
For more information kindly visit : http://www.bharatbook.com/
Contact us at :
Bharat Book Bureau
Ph.: + 91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter: http://twitter.com/#!/
# # #
Bharat Book Bureau is the leading business information aggregator providing market research reports and online databases. Bharatbook is also into the business of marketing conferences worldwide and undertakes custom research.